Alaunos Therapeutics Inc. (TCRT)
TCRT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.03
+188.57% on the day
Market cap
$7.7M
Nano cap
Revenue · 2025
$5K
-50.0% on 2024
Net income · 2025
-$4.2M
-83520.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | TCRT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001107421 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $5K |
| Net income | -$4.2M |
| Operating income | -$4.2M |
| Net margin | -83520.0% |
| Operating margin | -84500.0% |
| Revenue growth | -50.0% |
| Cash | $1.4M |
| Total assets | $3.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1543.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-09-21 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-10-13 |
| Latest proxy | DEFA14A | 2025-05-21 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CURX | Curanex Pharmaceuticals Inc | $4.88 | 0.00% | $7.7M |
| CALC | CalciMedica Inc. | $1.12 | -7.05% | $7.6M |
| CNSP | CNS Pharmaceuticals Inc. | $5.35 | +3.08% | $7.8M |
| APRE | Aprea Therapeutics Inc. | $0.6000 | +1.16% | $7.6M |
| XCUR | Exicure Inc. | $1.15 | +5.50% | $7.5M |
| INM | InMed Pharmaceuticals Inc. Common Shares | $1.33 | -2.21% | $7.3M |
| SNGX | Soligenix Inc. | $0.3348 | -4.80% | $7.3M |
| BOLT | Bolt Biotherapeutics Inc. | $4.29 | +1.06% | $8.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier